December 17, 2019
Investigators at the Case Western Reserve University School of Medicine discovered that blocking interleukin-1α (IL1α), a protein that controls inflammation in the gut markedly decreases the severity of intestinal inflammation in a mouse model of Crohn’s disease (CD). The anti-inflammatory effects of the biological therapies used to neutralize IL1α were […]